05.29.24 -- Designing Trial Protocols With Community Input
05/29/24 Life Science Leader Newsletter
Stay updated with breaking news from Cellicon Valley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
05/29/24 Life Science Leader Newsletter
SK pharmteco's acquisition of American genetic medicine developer CBM has given the Korean firm an advantage in the principal genetic medicine markets in the U.S. and Europe, according to SK Group.
/PRNewswire/ -- Integral Molecular is proud to announce that the Commonwealth of Pennsylvania has awarded the company $1M of funding through the Redevelopment...
The Center for Breakthrough Medicines (CBM), a contract development and manufacturing organization (CDMO) dedicated to addressing critical challenges associated with the commercialization of cell and gene therapies, has completed a successful...
/PRNewswire/ -- The Center for Breakthrough Medicines (CBM), a contract development, and manufacturing organization (CDMO), has launched its plasmid...